comparemela.com

Latest Breaking News On - Justin leong - Page 1 : comparemela.com

ResMed launches new bilevel sleep respiratory devices

ResMed (NYSE: RMD) announced today that it launched its AirCurve 11 series bilevel positive airway pressure devices in the U.S.

Resmed aircurveCarlosm nunezJustin leongDiego based resmedPersonal therapy assistantCare check inResmed chief medical officer

Increased Demand for Sleep Devices Spurs ResMed Growth

ResMed attributed the growth to increased demand for sleep devices, as well as strong growth across its mask product portfolio.

Katrin pucknatMick farrellJustin leongRob douglasMike flissResmed incYork universityNew york

ResMed Inc Announces Results for the Second Quarter of Fiscal Year 2024

Year-over-year revenue grows 12%, operating profit down 2%, non-GAAP operating profit up 20%Resumed share repurchase program, repurchased $50 million during quarter Note: A webcast of ResMed’s.

United statesRob douglasKatrin pucknatMick farrellJustin leongMike flissAustralian securities exchangeResmed incNew york stock exchangeYork stock exchangeYork universityJournal of the american medical associationExchange commissionSecond quarterLatin americaChief product officer

San Diego sleep apnea device maker ResMed cuts workforce, restructures executive team

ResMed will reduce its workforce by 5 percent. Additionally, its leadership structure has changed with new roles and two executive departures.

United statesWilliam blairKatrin pucknatJustin leongMike flissUrvashi tyagiMick farrellRob douglasSan diego basedSan diego countyWorker adjustmentRetraining notification actLatin americaNorth america

ResMed Overhauls C-Suite with New Operating Model

ResMed announced a new operating model to accelerate long-term growth, which introduces new leadership to the global executive team.

United statesMike flissUrvashi tyagiJustin leongAndrew priceLucile blaiseCarlos nunezBobby ghoshalRob douglasMick farrellAmy wakehamKatrin pucknatVered keisarBrett sandercockJim ellisTodd friedman

vimarsana © 2020. All Rights Reserved.